Sign inGet started

Canale-Theakston Carin

Insider CIK 1841613 · CDTX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-071,750— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-07875— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-071,400— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-072,125— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-072,125— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-0716,000— $00SEC↗
CDTX Cidara Therapeutics, Inc. D To issuer deriv2026-01-072026-01-0711,100— $00SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2025-06-182025-06-1811,100— $011,100SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2024-12-172024-12-1916,000— $016,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2024-07-182024-07-192,125— $02,125SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2023-06-222023-06-2342,500— $042,500SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2022-06-222022-06-2428,000— $028,000SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2021-06-232021-06-2417,500— $017,500SEC↗
CDTX Cidara Therapeutics, Inc. A Award deriv2021-01-222021-01-2535,000— $035,000SEC↗